We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFNX
11776
PUT
DELISTED
Pfenex Inc.
PFNX
-54,100
Closed -$690K
DLPH
11777
CALL
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-17,500
Closed -$292K
DLPH
11778
PUT
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-11,400
Closed -$190K
GMO
11779
DELISTED
General Moly, Inc.
GMO
-30,421
Closed -$3K
INWK
11780
CALL
DELISTED
InnerWorkings, Inc.
INWK
-34,400
Closed -$103K
INWK
11781
DELISTED
InnerWorkings, Inc.
INWK
-166,507
Closed -$498K
INWK
11782
PUT
DELISTED
InnerWorkings, Inc.
INWK
-66,700
Closed -$199K
MNTA
11783
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-836,737
Closed -$43.9M
SHLL.WS
11784
DELISTED
Tortoise Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
SHLL.WS
-281,740
Closed -$7.18M
KOL
11785
CALL
DELISTED
VanEck Vectors Coal ETF
KOL
-4,700
Closed -$366K
IDXG
11786
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
-11,858
Closed -$37K
SRAX
11787
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
-31,196
Closed -$83K
ADRE
11788
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
-27,349
Closed -$1.28M
TEUM
11789
CALL
DELISTED
Pareteum Corporation
TEUM
-140,000
Closed -$95K
TEUM
11790
DELISTED
Pareteum Corporation
TEUM
-75,667
Closed -$51K
TEUM
11791
PUT
DELISTED
Pareteum Corporation
TEUM
-88,900
Closed -$60K
COWN
11792
PUT
DELISTED
Cowen Inc. Class A Common Stock
COWN
-18,900
Closed -$308K
WPG
11793
CALL
DELISTED
Washington Prime Group Inc.
WPG
-3,678
Closed -$21K
WPG
11794
DELISTED
Washington Prime Group Inc.
WPG
-13,330
Closed -$78K
WPG
11795
PUT
DELISTED
Washington Prime Group Inc.
WPG
-10,178
Closed -$59K
PACD
11796
DELISTED
Pacific Drilling S.A. Common Shares
PACD
-175,494
Closed -$42K
TACO
11797
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
-105,995
Closed -$918K
MOBL
11798
DELISTED
MobileIron, Inc.
MOBL
-238,313
Closed -$1.67M
MOBL
11799
PUT
DELISTED
MobileIron, Inc.
MOBL
-26,300
Closed -$184K
EMKR
11800
CALL
DELISTED
Emcore Corp
EMKR
-1,280
Closed -$42K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.